| Financial Year |
March 31 2023 |
| Monetary Funds |
199,304,601.14 |
| Held-for-trading Financial Assets |
1,361,521,225.24 |
| Notes Receivable |
-- |
| Accounts Receivable |
80,020,325.00 |
| Advances to Suppliers |
18,702,897.27 |
| Other Receivables |
30,285,413.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
66,800,544.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,284,954.40 |
| Total Current Assets |
1,794,919,961.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
449,700,659.48 |
| Investment Properties |
11,877,388.73 |
| Fixed Assetes |
313,357,181.67 |
| Under-construction Projects |
23,252,201.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,147,831.61 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
108,069,316.26 |
| Deferred Income Tax Assets |
14,505,636.66 |
| Other Non-Current Assets |
3,580,059.46 |
| Sub-Total of Non-Current Assets |
1,320,351,644.35 |
| Total Assets |
3,115,271,605.52 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
122,576,874.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
58,856,068.35 |
| Taxes Payable |
15,144,089.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
74,056,096.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
136,672,163.94 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,282,420,957.33 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,678,439.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
220,431,781.10 |
| Total Liabilities |
1,502,852,738.43 |
| Paid-In Capital(Or Share Stock) |
240,000,000.00 |
| Capital Surplus |
514,882,508.86 |
| Surplus Reserve |
148,636,837.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
709,006,748.68 |
| Minority Stockholder's Interest |
607,312.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,611,811,554.82 |
| Owner's Equity（Stockholder's Equity） |
1,612,418,867.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,115,271,605.52 |
